Skip to main content

Knowledge Zone

Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The application period for the topics for new funding announcements opens in Germany

On April 19, 2024, the Innovation Committee at the Federal Joint Committee (G-BA) announced the start of the application period for submission of the proposed topics for new funding announcements for the projects in the field of health services research, as well as for the new forms of care.

The funding announcement for the (further) development of clinical guidelines does not fall under the application procedure. In this case, the priorities are defined by the Federal Ministry of Health. The topics cannot be proposed by the members of the Innovation Committee. The topics submission deadline is June 19, 2024.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.